DPM2 and liver cancer: Also, and at variance with DPM2 and 3, the DPM1 mRNA was upregulated (by 1.50-fold) in the Hep G2 hepatic cancer cell line, which suggests that DPM1 could be a potential biomarker with survival prognostic value in patients with hepatocellular carcinoma [113].